Oncology

Biograph 55

Pre-clinical stage company developing bispecific antibodies against a novel subset of immunosuppressive cells to treat resistant cancers.

Red Tree Participation
Led Series A

Red Tree Board Members

Jeremy Caldwell, Ph.D. (board chairman)
Jennifer Cochran, Ph.D.

Red Tree Board Observer

Samad Wahid, M.D.

Total Addressable Market
Red Tree Board Member(s)

Red Tree Board Members

Jeremy Caldwell, Ph.D. (board chairman)
Jennifer Cochran, Ph.D.

Red Tree Board Observer

Samad Wahid, M.D.

Red Tree Participation
Led Series A

Biograph 55

Oncology
Total Addressable Market
Red Tree Board Member(s)

Red Tree Board Members

Jeremy Caldwell, Ph.D. (board chairman)
Jennifer Cochran, Ph.D.

Red Tree Board Observer

Samad Wahid, M.D.

Red Tree Participation
Led Series A